NCT07110688 Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States
| NCT ID | NCT07110688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | No Condition |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2028-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-08-01 with a primary completion date of 2028-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological and biochemical sensing; a conversational virtual human platform to evoke naturalistic social processes; audiovisual affect recognition software; synchronization tools; and machine learning methods to model the multimodal data. The investigators will demonstrate the tools in healthy subjects without neural recordings and in patients with drug-resistant epilepsy who already have intracranial EEG (iEEG) electrodes implanted based on clinical criteria for standard monitoring to localize seizures, which is unrelated to our study.
Eligibility Criteria
For the healthy population, all subjects over the age of 18 who are able and willing to give informed consent will be eligible. For the epilepsy population, inclusion criteria are: * Patients who suffer from drug-resistant epilepsy and already have intracranial EEG (iEEG) electrodes implanted based on clinical criteria for their standard seizure localization (unrelated to our study) will be eligible. Most patients are healthy adults outside of their epilepsy. * Subjects \>= 18 are only included in this study. * All patients with the above conditions and with already-implanted electrodes who are willing to participate and able to cooperate and follow research instructions will be recruited.
Contact & Investigator
Maryam Shanechi, PhD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT07110688 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying No Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07110688 currently recruiting?
Yes, NCT07110688 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.
Where is the NCT07110688 trial being conducted?
This trial is being conducted at Downey, United States, Los Angeles, United States.
Who is sponsoring the NCT07110688 clinical trial?
NCT07110688 is sponsored by University of Southern California. The principal investigator is Maryam Shanechi, PhD at University of Southern California. The trial plans to enroll 90 participants.